Pleomorphic Carcinoma With EGFR and Concomitant Mutations Transformed From Lung Adenocarcinoma: A Case Report
Cancer Reports · 2026-04 · 9 (4)
DOI: 10.1002/cnr2.70546 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cancer Reports, online erschienen am 19.04.2026. Verfasst von Yuki Akazawa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma of Lung, Cell Transformation, Neoplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Transformation to small cell carcinoma, squamous cell carcinoma, and rarely, pleomorphic carcinoma (PC) has been reported to be found in EGFR ‐mutated lung cancer with acquired resistance to EGFR tyrosine kinase inhibitors (TKIs). However, evidence for underlying factors including genomic profiles associated with PC transformation has been lacking. Case We report a case of EGFR ‐mutated lung adenocarcinoma that transformed to PC confirmed by an autopsy after stereotactic radiotherapy and treatment with EGFR‐TKIs. Comprehensive genomic profiling of the autopsy tissue revealed BRAF G466A, KRAS L19F, and NF1 Q2324* mutations in addition to EGFR E746_A750del. Anti‐cancer treatments with radiation and EGFR‐TKIs accompanying these gene alterations might induce the histological transformation and resistance to EGFR‐TKIs.
Conclusion
This report adds an insight into the involvement of genetic events in histological transformation in EGFR ‐mutated lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
- Department of Pathology, Kitasato University School of Medicine, Sagamihara, Japan.
- Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Sagamihara, Japan.
ORCID-Profile: Yuki Akazawa, Takashi Sato, Jiichiro Sasaki, Katsuhiko Naoki
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Akazawa, Y., Sato, T., Yagami, Y., Kesen, Y., Furo, T., Watanabe, A., Endo, J., Nakano, M., Kurata, H., Matsuo, H., Nakahara, Y., Sasaki, J., & Naoki, K. (2026). Pleomorphic Carcinoma With EGFR and Concomitant Mutations Transformed From Lung Adenocarcinoma: A Case Report. Cancer Reports, 9(4). https://doi.org/10.1002/cnr2.70546
Vancouver
Akazawa Y, Sato T, Yagami Y, Kesen Y, Furo T, Watanabe A, et al. Pleomorphic Carcinoma With EGFR and Concomitant Mutations Transformed From Lung Adenocarcinoma: A Case Report. Cancer Reports. 2026;9(4). doi:10.1002/cnr2.70546
BibTeX
@article{Akazawa2026,
author = {Akazawa, Yuki and Sato, Takashi and Yagami, Yuri and Kesen, Yurika and Furo, Tomohiro and Watanabe, Atsuko and Endo, Jumpei and Nakano, Maito and Kurata, Hiroto and Matsuo, Hiromi and Nakahara, Yoshiro and Sasaki, Jiichiro and Naoki, Katsuhiko},
title = {Pleomorphic Carcinoma With EGFR and Concomitant Mutations Transformed From Lung Adenocarcinoma: A Case Report},
journal = {Cancer Reports},
year = {2026},
volume = {9},
number = {4},
doi = {10.1002/cnr2.70546}
}
EUVIMED